Molecular Partners AG
Molecular Partners AG is a Swiss Biotech company based in Schlieren (Zurich). It holds no Swissmedic authorisations for human medicines of its own and is listed here as a Biotech.
Key facts
| Sector | Biotech |
|---|---|
| City | Schlieren |
| Canton | Zurich |
| Authorisation holder | No |
| Medicines | Not available |
| Founded | 2004 |
| Employees | 51-200 |
| Parent group | Not available |
| Activity | DARPin protein therapeutics for oncology and infectious disease |
| Website | molecularpartners.com |
Medicines authorised in Switzerland
No medicine authorisation
Molecular Partners AG is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Biotechnological products, blood products, vaccines, cell and gene therapies and allergens.
Frequently asked questions
How many medicines does Molecular Partners AG have authorised in Switzerland?
Molecular Partners AG holds no Swissmedic authorisations for human medicines (as of 1 September 2026). The company is listed here as a Biotech business.
Where is Molecular Partners AG based?
The Swiss location recorded for Molecular Partners AG is Schlieren, Zurich.
Is Molecular Partners AG a Swissmedic authorisation holder?
No. Molecular Partners AG does not appear as an authorisation holder in the Swissmedic list. To reach the Swiss market, a foreign manufacturer needs an authorisation holder domiciled or represented in Switzerland.